Defibrillator Market Size, Growth, Trends & Analysis 2025

The global defibrillator market was valued at USD 9,836.8 million in 2018 and is projected to reach USD 21,184.6 million by 2032, exhibiting a CAGR of 5.7% during the forecast period (2018–2032). North America led the global market in 2018, accounting for 44.87% of the total share.

Defibrillation is widely recognized as an effective treatment for cardiac arrest caused by ventricular fibrillation. Defibrillators, electronic devices designed to restore normal heart rhythm, are extensively used to manage arrhythmias and sudden cardiac arrest (SCA). According to data published by the National Institutes of Health (NIH) in 2016, approximately 450,000 people experience sudden cardiac death annually. With the rising prevalence of out-of-hospital cardiac arrests, both developed and emerging nations are prioritizing the installation of external defibrillators in public spaces such as schools, hotels, shopping malls, and streets. Additionally, schools are incorporating awareness programs to educate children on handling cardiac emergencies. These combined efforts are expected to create significant growth opportunities for the defibrillator market by 2026.

Get a Free Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/defibrillator-market-100950

List Of Companies Profiled In Defibrillator Market:

• Asahi Kasei Corporation

• Philips Healthcare

• Defibtech, LLC.

• Cardiac Science

• Stryker

• CU Medical System Inc.

• Medtronic

• Boston Scientific Corporation

• Biotronik

• LivaNova Plc

• Abbott

• Microport

• Other prominent players

Market Segmentation:

The defibrillator market is segmented based on type into implantable cardioverter defibrillators (ICD) and external defibrillators. The ICD segment includes transvenous ICDs (further categorized into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy-defibrillators (CRT-Ds)) and subcutaneous ICDs. The CRT-D segment accounted for a significant market share in 2018 due to its higher adoption and cost, particularly in developed regions. The external defibrillator segment is further divided into automated external defibrillators (AEDs), semi-automatic & manual external defibrillators, and wearable external defibrillators, with AEDs widely used in public spaces due to government initiatives promoting their installation. Additionally, the market is segmented by end users, with hospitals and clinics holding the largest share due to the high prevalence of sudden cardiac arrests, while the public access segment is expected to grow due to increasing awareness and regulatory mandates for defibrillator installations in public places.

Defibrillator Market Regional Analysis:

North America Leads Market Growth with High Defibrillator Adoption

In 2018, North America generated revenue of USD 4,414.1 million and is expected to maintain its dominant position throughout the forecast period. The increasing deployment of external defibrillators in hospitals and public areas—such as schools, hotels, streets, and railway stations—is a key factor driving market growth. Additionally, a growing preference for subcutaneous ICDs due to rising patient awareness is further fueling ICD adoption across North America.

Regional Analysis:

Higher Adoption of Defibrillator Installations and Implants Strengthens Market Presence in North America

In 2018, North America generated revenue of USD 4,414.1 million and is expected to maintain its dominance in the defibrillator market throughout the forecast period. The increasing deployment of external defibrillators in hospitals and public spaces—such as schools, hotels, streets, and railway stations—aimed at preventing sudden cardiac arrest fatalities is a key factor driving market growth in the region. Additionally, the growing preference for subcutaneous implantable cardioverter defibrillators (ICDs), driven by rising patient awareness, is expected to further propel market expansion. Europe is projected to hold the second-largest market share by 2026, while the Asia Pacific region is experiencing rapid growth due to increasing adoption rates and the swift advancement of healthcare infrastructure.

Key Industry Developments:

• July 2021 – ZOLL Medical Corporation received FDA 510(k) clearance to introduce the TBI (traumatic brain injury) Dashboard feature on its Propaq M monitor and Propaq MD defibrillator. Previously available in international markets, this clinical decision-support tool for managing TBI patients is now accessible in the U.S.

• March 2021 – The Rankin government announced a USD 700,000 investment to equip all public schools in Nova Scotia with automated external defibrillators (AEDs). This initiative aims to enhance emergency preparedness and ensure the availability of life-saving devices during cardiac emergencies.

• April 2020 – Philips announced the resumption of manufacturing and shipping external defibrillators for the U.S. market. The decision followed the lifting of restrictions by the U.S. Food and Drug Administration (FDA) on the company's Emergency Care and Resuscitation (ECR) business, allowing the distribution of these critical devices.